Table 2.
CT imaging features of patients with COVID-19.
| CT findings | Number of studies | Number of patients (%) |
|---|---|---|
| Patterns of the lesion | ||
| Ground-glass opacity with consolidation | 60 | 768 (18%) |
| Ground-glass opacity | 60 | 2482 (65%) |
| Consolidation | 60 | 1259 (22%) |
| Crazy paving pattern | 24 | 575 (12%) |
| Reversed halo sign | 24 | 146 (1%) |
| Other signs in the lesion | ||
| Interlobular septal thickening | 23 | 691 (27%) |
| Air bronchogram sign | 23 | 531 (18%) |
| Distribution | ||
| Bilateral | 48 | 3952 (80%) |
| Unilateral | 48 | 641 (20%) |
| Right lung | 8 | 48 (62%) |
| Left lung | 8 | 29 (38%) |
| Number of lobes involved | ||
| One lobe | 13 | 278 (14%) |
| Two lobes | 13 | 299 (11%) |
| Three lobes | 13 | 250 (13%) |
| Four lobes | 13 | 212 (15%) |
| Five lobes | 14 | 384 (34%) |
| More than one lobe | 14 | 1145 (76%) |
| Lobe of lesion distribution | ||
| Left upper lobe | 14 | 731 (74%) |
| Left lower lobe | 20 | 504 (46%) |
| Right upper lobe | 19 | 455 (40%) |
| Right middle lobe | 15 | 326 (38%) |
| Right lower lobe | 17 | 784 (74%) |
| Other findings | ||
| Pleural effusion | 60 | 94 (1.6%) |
| Lymphadenopathy | 60 | 21 (0.7%) |
| Pulmonary nodules | 22 | 262 (9%) |